drugset / Trial / NCT07527221
Safety and Tolerability of ZE74-0282 in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
A first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses under fasted and fed conditions of ZE74-0282 administered orally in healthy volunteers.
Timeline
- Start
- 2026-04-16
- Primary completion
- 2026-11
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZE74-0282-0001 | Unknown | 100 mg | Oral |
Indications
No indication recorded.